Zurich, Switzerland

Thorsten Hornemann

USPTO Granted Patents = 2 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Zürich, CH (2017)
  • Zurich, CH (2020)

Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Thorsten Hornemann

Introduction

Thorsten Hornemann is a prominent inventor based in Zurich, Switzerland. With his innovative spirit and commitment to advancing scientific knowledge, he has made significant contributions to the field of genetics. He holds two patents that focus on identifying genetic mutations associated with sensory neuropathy, demonstrating his dedication to addressing medical challenges.

Latest Patents

Hornemann's latest patents involve detailed methodologies and kits designed to identify subjects at risk for sensory neuropathy-related diseases. Both patents emphasize the determination of mutations in the SPTLC2 gene, which have been linked to sensory neuropathies. These groundbreaking methods represent a significant step forward in understanding the genetic basis of these conditions and offer new avenues for diagnosis and treatment.

Career Highlights

Throughout his career, Hornemann has collaborated with various esteemed organizations. He has worked at Vib Vzw, where he contributed to research initiatives, and at the University of Antwerp, further enhancing his expertise in genetic research and innovation. His educational and professional endeavors have equipped him with the knowledge and skills to make meaningful advancements in his field.

Collaborations

In his professional journey, Hornemann has had the opportunity to work alongside talented individuals such as Annelies Rotthier and Vincent Timmerman. These collaborations have likely fostered valuable exchanges of ideas and have played a crucial role in the development of his patented technologies.

Conclusion

Thorsten Hornemann's contributions to the field of genetics through his patents on the SPTLC2 gene reflect a commitment to improving diagnostic methods for sensory neuropathy-related diseases. As he continues his work, his innovations hold the promise of enhancing our understanding of genetic conditions and improving patient outcomes in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…